Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Methylcobalamin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,229Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 1, 2023
    Enforcement Report - Week of February 1, 2023

    01 Feb 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416

    FDA
    01 Feb 2023
    Share Share
    Enforcement Report - Week of January 18, 2023
    Enforcement Report - Week of January 18, 2023

    18 Jan 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-18-2023-33998.pdf

    FDA
    18 Jan 2023
    Share Share
    Eisai: MHLW Grants ODD in Japan to Mecobalamin Ultrahigh-Dose Formulation
    Eisai: MHLW Grants ODD in Japan to Mecobalamin Ultrahigh-Dose Formulation

    27 May 2022

    // ASIAONE

    https://www.asiaone.com/business/eisai-mhlw-grants-orphan-drug-designation-japan-mecobalamin-ultrahigh-dose-formulation

    ASIAONE
    27 May 2022
    Share Share
    Drug industry cheers FSSAI’s removal of ban on methylcobalamin
    Drug industry cheers FSSAI’s removal of ban on methylcobalamin

    30 Dec 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=144961&sid=1

    PHARMABIZ
    30 Dec 2021
    Share Share
    Enforcement Report - Week of December 22, 2021
    Enforcement Report - Week of December 22, 2021

    22 Dec 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-22-2021-1640158210.pdf

    FDA
    22 Dec 2021
    Share Share
    Enforcement Report - Week of December 08, 2021
    Enforcement Report - Week of December 08, 2021

    08 Dec 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-08-2021-1638945311.pdf

    FDA
    08 Dec 2021
    Share Share